Cancer Clinical Trial Eligibility Criteria: Available Therapy in Non-Curative Settings: Guidance for Industry
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
July 27, 2022
July 27, 2022
d21a3c21-c758-4f3f-b215-edfe13aa09a3
Related Documents
Cancer Clinical Trial Eligibility Criteria: Patients with Organ Dysfunction or Prior or Concurrent Malignancies
Guidance DocumentJuly 10, 2020Center for Drug Evaluation and Research
Cancer Clinical Trial Eligibility Criteria: Brain Metastases
Guidance DocumentJuly 10, 2020Center for Drug Evaluation and Research
Cancer Clinical Trial Eligibility Criteria: Minimum Age Considerations for Inclusion of Pediatric Patients
Guidance DocumentJuly 10, 2020Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox